RT @AurelieRheumo: TNFi & Disease activity-guided dose optimization in RAâ¬ï¸prog of ADA or ETA daily dose (100%66
Tweet Content
TNFi & Disease activity-guided dose optimization in RA⬇️prog of ADA or ETA daily dose (100%66%50%0%)
10yrs followup in 170pts
⭐️74% tapered until full discontinuation
⭐️Median time to restart 8 mo
⭐️21% never restarted!
What's lacking? % of recovery
@Rheumnow OP0131 #EULAR23 https://t.co/Ms6lqQ7cWf
Show on Archive Page
On
Display in Search Results
On
PDQ
Off